Welcome to a new report of my Dividend Diary on the TEV Blog. Here, I report the development of a cash flow-oriented investment approach that focuses on generating a passive income through dividends. Against this background, the goal is not to outperform the market but to put food on the table through a regular income via dividends.
With the Dividend Diary, I document how a cash-flow investment approach can be part of well-balanced wealth management. To keep things simple, I have built three pillars:
- Active income.
- Passive income.
- Conversion.
Dividends fall into the last two categories. They are passive because they provide a cash flow without me going to work. Additionally, they are an essential pillar for conversion since they can be reinvested to generate even more income in the future. That is the Theory. Now let’s get down to practice.
My monthly income with dividends in February:
This month, my cash-flow approach generated the following income through dividends:
- AT&T (37.58 EUR)
- Bristol-Myers Squibb (34.16 EUR)
- CVS Health (8.48 EUR)
- General Mills (26.47 EUR)
- General Dynamics (7.93 EUR)
- Siemens (161.50 EUR)
- AbbVie (35.17 EUR)
- Omega Healthcare (24.95 EUR)
- Procter & Gamble (21.71 EUR)
- Realty Income (13.38 EUR)
- Apple (8.33 EUR)
- USA Financials ETF (73.63 EUR).
The total monthly income with dividends in February (after taxes) was: € 453.29 / appr. $ 478
Dividend income report check
Great financial performance compared to last year (+ 68 percent YoY).
Sales in February
I sold all my 62 shares of V. F. Corp as the management decided to cut the dividend shortly after they raised it by 2 percent, which destroyed the last bit of my remaining trust.
I also sold all my 200 Ping An Insurance shares, given the current geopolitical developments.
Aaaand, I also sold all my 6 Simon Property Group REIT shares.
Stock purchases in February
In February, I bought more shares of great companies so that the monthly income through dividends will continue to rise. As I implemented a few saving plans, I invested in much more companies than usual:
- Emerging Market ETF (15 shares)
- Talanx (55 shares)
- USA Financials ETF (27 shares)
Additional saving plans:
- Mayr-Melnhof Karton
- General Dynamics
- Valmet
- CVS Health
- Diageo
- Teamviewer
- Henkel
- Mensch & Maschine
- USU Software
- Stemmer Imaging
- AbbVie
- Automatic Data Processing
- Bristol-Myers Squibb
- Cisco Systems
- Generals Mills
- IBM
- Pfizer
- Qualcomm
- Realty Income.
